JAMA Dermatology

Diseases, Conditions, Syndromes

Annual costs estimated for wart treatment in the U.S. for 2015-2017

The estimated annual costs were $846 million for cutaneous warts for 2019 in the United States, and costs for anogenital warts were $127 million, according to a research letter published online April 27 in JAMA Dermatology.

Medications

Living review compares treatments for atopic dermatitis

Abrocitinib, 200 mg daily, and upadacitinib, 30 mg daily, seem to be slightly better than dupilumab for atopic dermatitis, according to a living review published online March 16 in JAMA Dermatology.

Medical economics

Debt valuation of private equity-backed dermatology groups down

Debt valuation of dermatology private equity-backed groups (DPEGs) decreased prior to the COVID-19 pandemic and then decreased further during the pandemic, according to a study published online March 9 in JAMA Dermatology.

Oncology & Cancer

Patients with rare skin cancer face 40% recurrence rate

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40%—markedly higher than the recurrence rates for melanoma and other skin cancers, according to research published today in JAMA Dermatology.

Health

The bald facts on how best to fight hair loss in men

Nearly all men see their hairline recede or a bald spot emerge at some point in their life. For those looking to slow the march of time, a new study helps sort out which hair-loss medications work best.

Diseases, Conditions, Syndromes

Common virus may cause serious disease in transplant patients

A common virus that causes no harm in most people may be a danger to organ transplant recipients and other immunocompromised people, say researchers at Columbia University Irving Medical Center.

page 8 from 37